Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.
What This Page Explains
Urolithin A has one of the strongest human clinical evidence bases of any longevity compound. Unlike most compounds studied primarily in cell culture and animal models, urolithin A has been tested in multiple randomised, double-blind, placebo-controlled human trials with meaningful functional endpoints. This page summarises the specific benefits demonstrated in human clinical research, organised by outcome and evidence strength. It is critical to note that while the evidence is strong for mitochondrial and muscle benefits, claims about disease treatment or prevention are not supported — urolithin A is a cellular health supplement, not a drug.
The Science on This Page Points to One Conclusion
Your cells need targeted support — not more vitamins, not more caffeine, not more wishful thinking. Real compounds for real cellular mechanisms.
Detailed Evidence
MITOCHONDRIAL HEALTH BENEFITS The 2022 JAMA Network Open RCT is the cornerstone human evidence. Adults aged 40-65 received placebo, 500mg/day, or 1,000mg/day of urolithin A for four months. At 500mg/day: mitochondrial health biomarkers significantly improved; mitophagy-related gene expression increased in skeletal muscle; and cellular energy markers improved. This is the most direct human evidence for mitochondrial quality improvement from any natural compound. MUSCLE ENDURANCE BENEFITS At 1,000mg/day in the JAMA trial: muscle endurance improved (measured by hand exercise and 6-minute walk test); fatigue resistance increased; and inflammatory markers were reduced by up to 53%. These are functional outcomes — not just biomarkers — showing real-world performance improvement in middle-aged adults. IMMUNE REJUVENATION BENEFITS A 2025 randomised double-blind trial showed urolithin A expanded T memory stem cells (TSCM) in older adults. TSCM are the long-lived reservoir of immune memory. This is the first evidence of immune rejuvenation in humans from any compound — a potentially significant finding for aging immune health. CARDIOVASCULAR HEALTH BENEFITS A 2025 iScience study showed urolithin A improved cardiovascular health biomarkers and reduced cardiac function decline in aging and heart failure models. While this is preclinical/early human evidence, it suggests potential cardiovascular applications. INFLAMMATORY MARKER REDUCTION At 1,000mg/day, the JAMA trial showed inflammatory markers reduced by up to 53%. Chronic low-grade inflammation (inflammaging) is a hallmark of aging and contributor to multiple age-related diseases. Reducing inflammatory markers is a meaningful cellular health benefit. WHAT THE EVIDENCE DOES NOT SHOW No published trial demonstrates that urolithin A treats, cures, or prevents any disease. The evidence supports cellular health, mitochondrial quality, muscle endurance, and inflammatory marker improvements in healthy adults — not disease treatment.
Evidence Hierarchy
Systematic Reviews & Meta-Analyses
Multiple high-quality trials combined
Randomized Controlled Trials (RCTs)
Gold standard for treatment efficacy
Observational Studies
Can show associations, not causation
Case Reports & Expert Opinion
Hypothesis-generating only
Preclinical (Lab/Animal) Studies
Should NOT be extrapolated to humans
What Happened When 3,000 People Targeted Their Mitochondria
Real people. Real results. See how a cellular approach to energy changed everything for people just like you.
Study Quality Indicators
Higher Quality Indicators
- Large sample size (hundreds to thousands)
- Randomized and blinded design
- Placebo-controlled comparison
- Published in peer-reviewed journals
- Replicated in multiple studies
- Registered trial protocol before starting
Lower Quality Indicators
- Small sample size (under 100)
- No control group or blinding
- Manufacturer-funded with conflicts
- Only animal/cell studies
- Never replicated
- Published in predatory journals
Important Limitations
- • Supplement research often has methodological limitations
- • Results from one study may not generalize to all people
- • Marketing claims often exceed what research supports
- • Absence of evidence is not evidence of absence
- • Individual response to supplements varies widely
Quick Answers
What are the proven benefits of urolithin A?
Human trials show improved mitochondrial health biomarkers, increased muscle endurance, reduced inflammatory markers (up to 53%), and expanded immune T memory stem cells. These are the strongest evidence-based benefits.
Does urolithin A improve energy?
The JAMA trial showed improved mitochondrial health biomarkers at 500mg/day and improved muscle endurance at 1,000mg/day — both consistent with improved cellular energy production.
Does urolithin A help muscle function?
Yes. At 1,000mg/day, the JAMA trial showed improved muscle endurance (hand exercise and 6-minute walk test) and fatigue resistance in adults aged 40-65.
Does urolithin A reduce inflammation?
Yes. At 1,000mg/day, the JAMA trial showed inflammatory markers reduced by up to 53% in adults aged 40-65 over four months.
Does urolithin A support immune health?
A 2025 trial showed urolithin A expanded T memory stem cells (TSCM) in older adults — the first evidence of immune rejuvenation in humans. This is an early but significant finding.
Does urolithin A help cardiovascular health?
A 2025 iScience study showed improved cardiovascular biomarkers and reduced cardiac function decline in aging models. Human cardiovascular evidence is still early-stage.
How quickly does urolithin A work?
The JAMA trial measured outcomes at four months. Some biomarker changes may occur sooner, but functional benefits (muscle endurance) were measured at the four-month endpoint.
Does urolithin A help with aging?
Urolithin A targets a key hallmark of aging (mitochondrial dysfunction) by activating mitophagy. It is best understood as a cellular health supplement supporting mitochondrial quality, not an anti-aging drug.
Can urolithin A treat disease?
No. No published trial demonstrates urolithin A treats, cures, or prevents any disease. The evidence supports cellular health benefits in healthy adults, not disease treatment.
Does urolithin A help with fatigue?
At 1,000mg/day, the JAMA trial showed improved fatigue resistance. This is consistent with improved mitochondrial function and reduced inflammatory markers.
Does urolithin A help older adults?
The 2025 immune trial was specifically in older adults and showed TSCM expansion. The JAMA trial included adults 40-65. Both suggest relevance for aging populations.
Is urolithin A better than other mitochondrial supplements?
Urolithin A has the strongest human RCT evidence for mitophagy activation specifically. Other compounds (NAD+ precursors, CoQ10) support different aspects of mitochondrial function.
Does urolithin A help brain function?
Preclinical studies suggest urolithin A may cross the blood-brain barrier and support neuronal mitochondrial health. Human cognitive evidence has not been published yet.
What dose is needed for benefits?
The JAMA trial showed mitochondrial benefits at 500mg/day and additional muscle/inflammatory benefits at 1,000mg/day. Both doses produced meaningful effects.
Does urolithin A help exercise recovery?
Improved muscle endurance and reduced inflammatory markers suggest potential exercise recovery benefits, though this has not been directly measured in endurance athletes.
Key Research Facts
The 2022 JAMA Network Open RCT showed 500mg/day of urolithin A significantly improved mitochondrial health biomarkers in adults aged 40-65 over four months.
Strong EvidenceJAMA Network Open — Singh et al. 2022
At 1,000mg/day, the JAMA trial showed improved muscle endurance (hand exercise, 6-minute walk) and fatigue resistance in adults aged 40-65.
Strong EvidenceJAMA Network Open — Singh et al. 2022
At 1,000mg/day, inflammatory markers were reduced by up to 53% in the JAMA trial — a meaningful anti-inflammatory effect.
Strong EvidenceJAMA Network Open — Singh et al. 2022
A 2025 trial showed urolithin A expanded T memory stem cells (TSCM) in older adults — the first evidence of immune rejuvenation in humans.
Strong EvidencePMC12618261 — 2025 immune trial
A 2025 iScience study showed urolithin A improved cardiovascular biomarkers and reduced cardiac function decline in aging models.
Moderate EvidenceiScience — 2025 cardiovascular study
Urolithin A is the only natural compound with robust human RCT evidence specifically for mitophagy activation in skeletal muscle.
Strong EvidenceClinical trial review — urolithin A evidence base
Benefits were measured at four months of daily supplementation — consistent cellular support is needed, not occasional dosing.
Strong EvidenceJAMA Network Open — Singh et al. 2022
No published trial demonstrates urolithin A treats, cures, or prevents any disease — the evidence supports cellular health benefits only.
Strong EvidenceClinical literature review — PubMed search
Urolithin A received FDA GRAS status in 2020 — supporting its safety profile for long-term supplementation.
Strong EvidenceFDA GRAS Notice — Amazentis, 2020
No serious adverse events have been reported in any published study at recommended doses, across multiple human clinical trials.
Strong EvidenceClinical safety review — published trial data
Citations & External Resources
JAMA Network Open — Singh et al. 2022 (Mitochondrial Health RCT)
PMC — 2025 Immune Rejuvenation Trial
iScience — 2025 Cardiovascular Study
FDA GRAS Notice — Urolithin A (Amazentis, 2020)
PubMed — Urolithin A Clinical Trials
Nature Metabolism — Urolithin Metabotypes Study (2021)
The 5-Ingredient Formula That Targets All 12 Hallmarks of Aging
See exactly how each ingredient addresses the cellular mechanisms you just read about — backed by the same research cited on this page.
Related Reading
Urolithin A: The Complete Evidence-Based Guide
Urolithin A: How It Works (Mitophagy Mechanisms)
Urolithin A Side Effects & Safety
References (3)
Written by
ReCellence™ Editorial Team
Health Content Specialists
Medically reviewed by
Medical Review Board
MD, PhD
Last updated: March 8, 2026
Last medical review: March 8, 2026